MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Characterization of novel alpha-synuclein aggregation model of Parkinson’s disease

    A. Singh, S. Reunanen, A. Panhelainen, M. Voutilainen (Helsinki, Finland)

    Objective: To establish and characterize a robust alpha-synuclein (aSyn) aggregation pathology research model to allow efficient drug development platform for Parkinson's disease (PD). Background: PD…
  • MDS Virtual Congress 2020

    The cold hand sign in multiple system atrophy: prevalence, associated factors and impact on survival

    B. Cao, L.Y Zhang, QQ. Wei, R.W Ou, H.F Shang (Chengdu, China)

    Objective: The purpose of the study was to investigate the prevalence of and factors associated with cold hand sign in multiple system atrophy (MSA) patients,…
  • MDS Virtual Congress 2020

    Clinical profile and cerebral metabolic characteristic of cognitive impairments in multiple system atrophy

    C. Shen, F.T Liu, JJ. Ge, P. Wu, C.T Zuo, J. Wang (Shanghai, China)

    Objective: This study aimed to characterize the cognitive profiles of multiple system atrophy (MSA) and explore the possible mechanisms involved using 18F-fluorodeoxyglucose (FDG) Positron Emission…
  • MDS Virtual Congress 2020

    Decline in the midbrain-to-pons ratio over one year can support the differentiation between PSP and IPD

    S. Kannenberg, L. Dinkelbach, J. Caspers, A. Moldovan, S. Ferrea, M. Südmeyer, M. Butz, A. Schnitzler, C. Hartmann (Düsseldorf, Germany)

    Objective: The midbrain-to-pons ratio (MTPR) is considered as an important diagnostic biomarker to differentiate between progressive supranuclear palsy (PSP) and idiopathic Parkinson’s disease (IPD). Here,…
  • MDS Virtual Congress 2020

    Apomorphine as a Diagnostic tool to Identify Levodopa Responsive Atypical Parkinsonism

    M. Faisal, D. Sreenivasa, R. Jayachandran, R. Seetharam, R. Iyer, P. Kukkle (Bengaluru, India)

    Objective: To assess the efficacy of apomorphine in identification of levodopa responsive atypical parkinsonism. Background: Management of atypical parkinsonism is a challenge. Most of these…
  • MDS Virtual Congress 2020

    Burden of Care-Partners of People with Parkinson’s Disease: Findings from Parkinson’s Disease Real-World Impact Assessment (PRISM) Study

    E. Tolosa, J. Ferreira, A. Antonini, A. Lees, T. Foltynie, G. Ebersbach, O. Rascol, J.F Rocha, D. Magalhães, P. Soares-da-Silva (Barcelona, Spain)

    Objective: To evaluate the characteristics and burden of the care-partners of people with Parkinson’s disease (PwP). Background: The burden of care-partners of PwP is currently…
  • MDS Virtual Congress 2020

    Clinical outcome of 6-pyruvoyl-tetrahydropterin synthase deficiency (PTPSd)

    F. Nardecchia, F. Manti, S. Galosi, A. Burlina, D. Gueraldi, M. Donati, F. Pochiero, a. Cassio, F. Porta, M. Spada, C. Carducci, C. Carducci, S. Paci, G. Banderali, M. Schiaffino, N. Blau, V. Leuzzi (Rome, Italy)

    Objective: To assess morbility and clinical outcome of patients affected by defect of tetrahydrobiopterin (BH4) synthesis due to PTPSd. Background: PTPSd is a treatable genetic disorder…
  • MDS Virtual Congress 2020

    Predictors of Falls with Injuries in People with Parkinson’s Disease

    H. Meira, I. Rosa, G. Valença, J. Oliveira-Filho, L. Almeida (Salvador, Brazil)

    Objective: To identify predictors of falls with injuries in people with Parkinson’s disease (PD). Background: Falls are common in people with PD and can lead…
  • MDS Virtual Congress 2020

    Physical Therapy and Deep Brain Stimulation in Parkinson Disease: A Pilot Randomized Controlled Trial

    R. Duncan, K. Rawson, G. Earhart, L. Van Dillen, J. Perlmutter (Saint Louis, MO, USA)

    Objective: To determine the safety, feasibility, and preliminary efficacy of physical therapy (PT) for people with Parkinson disease (PD) who have deep brain stimulation (DBS).…
  • MDS Virtual Congress 2020

    Physical Therapy Role with Differential Diagonosis and Treatment with Dizziness and Multiple System Atrophy: A Case Study

    J. Liu (Sacramento, CA, USA)

    Objective: The purpose of this case study is to address the role of physical therapy (PT) in a case of complex dizziness, progressive symptoms, and…
  • « Previous Page
  • 1
  • …
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley